Back

CEASE AF: Primary Efficacy and Safety Endpoints - discussion

17 April 2023 (14:10 - 14:15)
Organised by:
Congress Presentation Part of: Late Breaking Science - Day 2 Atrial Fibrillation (AF) EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Stylianos Tzeis

Mitera Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
AdaptResponse: A randomized study of synchronized LV pacing
Professor B. Wilkoff (Cleveland, US)
Slides Video
Presentation thumbnail
AdaptResponse: A randomized study of synchronized LV pacing - discussion
Professor J. Steffel (Zurich, CH)
Slides Video
Presentation thumbnail
Extended ECG monitoring in HCM
Mr J. Caro Codon (Madrid, ES)
Slides Video
Presentation thumbnail
Extended ECG monitoring in HCM - discussion
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
AIDEG-VTA - ICD EG during VT ablation
Professor J. Almendral Garrote (Boadilla del Monte, ES)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science - Day 2
Video

The Event

Event poster

EHRA 2023

17 April 2023 14:10 CET
You may be interested in
thumbnail
Congress Presentation
Three-year safety and effectiveness of Hybrid Ablation versus Catheter Ablation: Final results of the CEASE-AF trial
30 March 2025
thumbnail
Congress Session
How to ablate persistent atrial fibrillation (AF) beyond pulmonary vein isolation (PVI)
4 April 2022
thumbnail
Congress Presentation
Hybrid Versus Catheter Ablation for Persistent Atrial Fibrillation and Heart Failure: The HALT AF Randomised Trial
29 August 2026
thumbnail
Congress Presentation
Hybrid ablation approach for long-standing persistent atrial fibrillation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources